Actively Recruiting
Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
Led by Brigham and Women's Hospital · Updated on 2026-03-05
160
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Lung cancer patients undergoing upfront surgery, highly benefit from a systematic lymph node dissection in the mediastinum and in the surgical specimens. The latter is performed by the pathologist. Developing a standardized technique to dissect the lobectomy specimen has the potential of maximizing the retrieval of all N1 stations lymph nodes. The investigators believe that the adoption of such technique will improve lung cancer staging and identify a higher number of patients that qualify for adjuvant therapies.
CONDITIONS
Official Title
Maximizing Lymph Node Dissection on Fresh and Fixed Lung Cancer Resection Specimens
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects with a lung nodule or mass who are eligible to undergo a lobectomy.
- Subject without any metastasis present.
- Subjects who have peripheral lung nodule location.
- Subjects must be 18 years of age or older.
You will not qualify if you...
- Subjects who received preoperative chemotherapy or radiotherapy.
- Subjects who have a lung nodule located in a central location. Central tumors are defined by those infiltrating the lobar airway.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Brigham and Womens Hospital
Boston, Massachusetts, United States, 02115
Actively Recruiting
Research Team
P
Paula Ugalde Figueroa, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here